1. 2012
  2. Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

    Petoumenos, K., Worm, S. W., Fontas, E., Weber, R., de Wit, S., Bruyand, M., Reiss, P., El-Sadr, W., D'Arminio Monforte, A., Friis-Møller, N., Lundgren, J. D., Law, M. G. & AUTHOR GROUP, 2012, In: Journal of the International AIDS Society. 15, 2, p. 17426

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults >= 60 years of age

    Vermeulen, J. N., Lange, J. M. A., Tyring, S. K., Peters, P. H., Nunez, M., Poland, G., Levin, M. J., Freeman, C., Chalikonda, I., Li, J., Smith, J. G., Caulfield, M. J., Stek, J. E., Chan, I. S. F., Vessey, R., Schödel, F. P., Annunziato, P. W., Schlienger, K. & Silber, J. L., 2012, In: Vaccine. 30, 5, p. 904-910

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Temporary antiretroviral treatment during primary HIV-1 infection has a positive impact on health-related quality of life: data from the Primo-SHM cohort study

    Grijsen, M. L., Koster, G. T., van Vonderen, M. G. A., van Kasteren, M., Kootstra, G. J., Steingrover, R., de Wolf, F., Prins, J. M., Nieuwkerk, P. T. & AUTHOR GROUP, 2012, In: HIV medicine. 13, 10, p. 630-635

    Research output: Contribution to journalArticleAcademicpeer-review

  5. The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study

    AUTHOR GROUP, Cain, L. E., Phillips, A., Lodi, S., Sabin, C., Bansi, L., Justice, A., Tate, J., Logan, R., Robins, J. M., Sterne, J. A. C., van Sighem, A., de Wolf, F., Bucher, H. C., Elzi, L., Touloumi, G., Vourli, G., Esteve, A., Casabona, J., del Amo, J., & 31 othersMoreno, S., Seng, R., Meyer, L., Pérez-Hoyos, S., Muga, R., Abgrall, S., Costagliola, D., Hernán, M. A., Ainsworth, J., Anderson, J., Babiker, A., Chadwick, D., Delpech, V., Dunn, D., Gras, L. A. J., Prins, J. M., Boer, K., Bos, J. C., Geerlings, S. E., Godfried, M. H., Kuijpers, T. W., Lange, J. M. A., van der Meer, J. T. M., Nellen, F. J. B., Pajkrt, D., van der Poll, T., Reiss, P., Scherpbier, H. J., van der Valk, M., van Vugt, M. & Wit, F. W. M. N., 2012, In: AIDS (London, England). 26, 13, p. 1691-1705

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery

    Hermans, S. M., van Leth, F., Kiragga, A. N., Hoepelman, A. I. M., Lange, J. M. A. & Manabe, Y. C., 2012, In: Tropical medicine & international health. 17, 12, p. 1527-1533

    Research output: Contribution to journalArticleAcademicpeer-review

  7. 2011
  8. Cardiovascular disease prevention in rural Nigeria in the context of a community based health insurance scheme: QUality Improvement Cardiovascular care Kwara-I (QUICK-I)

    Hendriks, M., Brewster, L., Wit, F., Bolarinwa, O. A., Odusola, A. O., Redekop, W., Bindraban, N., Vollaard, A., Alli, S., Adenusi, P., Agbede, K., Akande, T., Lange, J. & Schultsz, C., 2011, In: BMC public health. 11, p. 186

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Development and evaluation of a patient centered cardiovascular health education program for insured patients in rural Nigeria (QUICK - II)

    Odusola, A. O., Hendriks, M., Schultsz, C., Stronks, K., Lange, J., Osibogun, A., Akande, T., Alli, S., Adenusi, P., Agbede, K. & Haafkens, J., 2011, In: BMC public health. 11, 1, p. 171

    Research output: Contribution to journalArticleAcademicpeer-review

  10. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

    Hamers, R. L., Wallis, C. L., Kityo, C., Siwale, M., Mandaliya, K., Conradie, F., Botes, M. E., Wellington, M., Osibogun, A., Sigaloff, K. C. E., Nankya, I., Schuurman, R., Wit, F. W., Stevens, W. S., van Vugt, M., de Wit, T. F. R. & AUTHOR GROUP, 2011, In: Lancet infectious diseases. 11, 10, p. 750-759

    Research output: Contribution to journalArticleAcademicpeer-review

  11. Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group

    Benard, A., van Sighem, A., Taieb, A., Valadas, E., Ruelle, J., Soriano, V., Calmy, A., Balotta, C., Damond, F., Brun-Vezinet, F., Chene, G., Matheron, S. & AUTHOR GROUP, 2011, In: Clinical infectious diseases. 52, 10, p. 1257-1266

    Research output: Contribution to journalArticleAcademicpeer-review

  12. Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first test

    Gras, L., van Sighem, A., Bezemer, D., Smit, C., Wit, F., de Wolf, F. & AUTHOR GROUP, 2011, In: AIDS (London, England). 25, 6, p. 813-818

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1...4 5 6 7 8 9 10 11 ...48 Next

ID: 69232